Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

1993 ◽  
Vol 71 (11) ◽  
pp. 909-915 ◽  
Author(s):  
Uri Goldbourt ◽  
Solomon Behar ◽  
Henrietta Reicher-Reiss ◽  
Jacob Agmon ◽  
Elieser Kaplinsky ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document